To access this element change to forms mode OFF
Grant Award View - GA352111
Na(+)-dysregulating antimalarials: blocking the roads to resistance by...
GA ID:
GA352111
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
6-Nov-2023
Publish Date:
8-Jan-2024
Category:
Medical Research
Grant Term:
1-Jan-2024 to 31-Dec-2027
Value (AUD):
$838,252.87
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 22/23 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Na(+)-dysregulating antimalarials: blocking the roads to resistance by understanding PfATP4 and its place in parasite physiology
Purpose:
The most deadly malaria parasite has acquired resistance to most antimalarials, and there is a danger of malaria becoming an untreatable disease. Cipargamin is a promising new antimalarial that targets a protein needed for salt balance in the parasite. In this project we seek to understand the ways in which parasites can protect themselves from cipargamin, and explore strategies for preventing resistance. We will also characterise other proteins that regulate salt balance in malaria parasites.
GO ID:
GO Title:
Ideas Grants 2023
InternalReferenceId:
2023/GNT2028714
Selection Process:
Open Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Australian National University
Recipient ABN:
52 234 063 906
Grant Recipient Location
Suburb:
Canberra City
Town/City:
Canberra City
Postcode:
2600
State/Territory:
ACT
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT
Postcode:
Country:
AUSTRALIA